Authors: | Traina, T. A.; Kaufman, P. A.; Cadoo, K. A.; Hudis, C. A.; Chang, C.; Berrak, E.; Song, J.; Cox, D.; Seidman, A. D. |
Abstract Title: | Phase 2 feasibility study of dose-dense doxorubicin and cyclophosphamide (AC) followed by eribulin mesylate with or without prophylactic growth factor (GF) for adjuvant treatment of early-stage breast cancer (EBC) |
Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
Journal Title: | Journal of Clinical Oncology |
Volume: | 32 |
Issue: | 15 Suppl. |
Meeting Dates: | 2014 May 30-Jun 3 |
Meeting Location: | Chicago, IL |
ISSN: | 0732-183X |
Publisher: | American Society of Clinical Oncology |
Date Published: | 2014-05-20 |
Language: | English |
ACCESSION: | WOS:000358613201988 |
PROVIDER: | wos |
DOI: | 10.1200/jco.2014.32.15_suppl.TPS670 |
Notes: | Meeting Abstract: TPS670 -- Source: Wos |